Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,242Revenue (TTM) $M273Net Margin (%)-13.4Altman Z-Score3.5
Enterprise Value $M1,177EPS (TTM) $-1.0Operating Margin %-11.1Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.2Pre-tax Margin (%)-13.4Higher ROA y-yN
Price/Book5.810-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %--Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow369y-y EBITDA Growth Rate %-190.1ROA % (ttm)-9.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-16.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M37.3ROIC % (ttm)-18.0Gross Margin Increase y-yN

Gurus Latest Trades with PCRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCRXMariko Gordon 2016-09-30 Add0.3%$33.48 - $45.51
($39.18)
$ 32.35-17%Add 13.31%1,220,044
PCRXRon Baron 2016-09-30 Reduce-0.01%$33.48 - $45.51
($39.18)
$ 32.35-17%Reduce -61.10%21,921
PCRXKen Fisher 2016-09-30 Add$33.48 - $45.51
($39.18)
$ 32.35-17%Add 1.37%6,282
PCRXMariko Gordon 2016-06-30 Add0.25%$33.73 - $64.56
($49.21)
$ 32.35-34%Add 11.79%1,076,724
PCRXRon Baron 2016-06-30 Add0.01%$33.73 - $64.56
($49.21)
$ 32.35-34%Add 247.61%56,351
PCRXMariko Gordon 2016-03-31 Add0.05%$45.36 - $76.79
($58.89)
$ 32.35-45%Add 1.57%963,184
PCRXRon Baron 2016-03-31 Add$45.36 - $76.79
($58.89)
$ 32.35-45%Add 25.44%16,211
PCRXMariko Gordon 2015-12-31 Reduce-0.24%$36.62 - $79.39
($57.34)
$ 32.35-44%Reduce -9.00%948,283
PCRXKen Fisher 2015-12-31 Add$36.62 - $79.39
($56.9)
$ 32.35-43%Add 4.15%6,197
PCRXRon Baron 2015-12-31 Add$36.62 - $79.39
($57.34)
$ 32.35-44%Add 87.29%12,923
PCRXMariko Gordon 2015-09-30 Add0.94%$40.95 - $70
($61.25)
$ 32.35-47%Add 56.02%1,042,012
PCRXGeorge Soros 2015-09-30 Sold Out -0.39%$40.95 - $70
($61.25)
$ 32.35-47%Sold Out0
PCRXRon Baron 2015-09-30 Buy $40.95 - $70
($61.25)
$ 32.35-47%New holding6,900
PCRXKen Fisher 2015-09-30 Add$40.95 - $70
($61.25)
$ 32.35-47%Add 23.96%5,950
PCRXGeorge Soros 2015-06-30 Buy 0.39%$65.78 - $92.39
($78.91)
$ 32.35-59%New holding531,800
PCRXRon Baron 2015-06-30 Sold Out -0.03%$65.78 - $92.39
($78.91)
$ 32.35-59%Sold Out0
PCRXMariko Gordon 2015-06-30 Add0.02%$65.78 - $92.39
($78.91)
$ 32.35-59%Add 1.19%667,877
PCRXJoel Greenblatt 2015-06-30 Sold Out -0.01%$65.78 - $92.39
($78.91)
$ 32.35-59%Sold Out0
PCRXMariko Gordon 2015-03-31 Reduce-0.12%$85.01 - $119.27
($101.46)
$ 32.35-68%Reduce -4.30%659,998
PCRXGeorge Soros 2015-03-31 Sold Out -0.084%$85.01 - $119.27
($101.46)
$ 32.35-68%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STACK DAVID MCEO and Chairman 2016-11-15Sell15,000$37.28-13.22view
Scibetta James SPresident 2016-11-15Sell20,000$36.5-11.37view
STACK DAVID MCEO and Chairman 2016-08-15Sell15,000$45.32-28.62view
Scibetta James SPresident 2016-08-15Sell25,000$45.21-28.45view
Riker Lauren BullaroVice President, Finance 2016-06-07Sell938$47.66-32.12view
Williams Kristen MarieCAO and General Counsel 2016-06-06Sell600$47.2-31.46view
Kronenfeld Mark A.Director 2016-06-06Sell900$46.95-31.1view
Brege LauraDirector 2016-06-06Sell1,000$46.95-31.1view
HASTINGS PAUL JDirector 2016-06-06Sell1,136$46.95-31.1view
STACK DAVID MCEO and Chairman 2016-04-15Sell25,000$64.14-49.56view

Press Releases about PCRX :

Quarterly/Annual Reports about PCRX:

News about PCRX:

Articles On GuruFocus.com
Baron Funds Comments on Pacira Pharmaceuticals Aug 10 2016 
Baron Funds Comments on Pacira Pharmaceuticals Inc. May 19 2016 
Baron Funds Comments on Pacira Pharmaceuticals Inc. Feb 25 2016 
Mariko Gordon Nearly Doubles Stake in Forward Air Jan 04 2016 
Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals Feb 04 2015 
Mariko Gordon's First Quarter Top Five May 15 2014 
Baron Funds Comments on Pacira Pharmaceuticals Mar 05 2014 
Weekly CFO Buys Highlight: PCRX, UGI, MIG, GLT, IOSP Feb 27 2011 
Weekly CFO Buys Highlight: REFR, UGI, PCRX, NOIZ Feb 21 2011 
Pacira Pharmaceuticals Inc. (PCRX) CFO James S Scibetta buys 5,000 Shares Feb 16 2011 

More From Other Websites
Should You Buy Pacira Pharmaceuticals Inc (PCRX)? Dec 08 2016
Coverage initiated on Pacira Pharma by Goldman Dec 01 2016
ETFs with exposure to Pacira Pharmaceuticals, Inc. : November 30, 2016 Nov 30 2016
Pacira Pharmaceuticals and GeneAlign Announce Partnership to Develop Low-Opioid Pain Management... Nov 29 2016
American College of Surgeons Launches Education Program on Opioids and Surgery: Use, Abuse, and... Nov 22 2016
Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PCRX-US :... Nov 22 2016
American College of Surgeons Launches Education Program on Opioids and Surgery: Use, Abuse, and... Nov 22 2016
ETFs with exposure to Pacira Pharmaceuticals, Inc. : November 18, 2016 Nov 18 2016
Pacira Pharmaceuticals, Inc. :PCRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 16,... Nov 16 2016
Should You Be Bullish on Home Bancshares Inc (HOMB), Calpine Corporation (CPN) & Two Other Stocks? Nov 15 2016
Pacira Pharmaceuticals Unveils Virtual Reality Training Simulation to Enhance Administration... Nov 11 2016
Pacira Pharmaceuticals Unveils Virtual Reality Training Simulation to Enhance Administration... Nov 11 2016
Correction: Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in November Nov 10 2016
Correction: Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in November Nov 10 2016
Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in November Nov 10 2016
Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in November Nov 10 2016
PACIRA PHARMACEUTICALS, INC. Financials Nov 08 2016
Mattress Firm (MFRM) Acquisition Powers 40 North Management to Impressive Q3 Returns Nov 05 2016
Biogen (BIIB) Helped Healthcare Funds Like This One Dominate The Third Quarter Nov 04 2016
Pacira (PCRX) Misses Q3 Earnings Estimates, Beats on Sales Nov 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)